FDA Reviewing Benefits of Bristol-Myers Squibb Company, Sanofi-Aventis (France) Blood Thinner Plavix

Federal health officials are investigating whether the blockbuster blood thinner Plavix is less effective in some patients. The Food and Drug Administration is studying reports that taking certain heartburn medications alongside Plavix decreases the benefits of the drug. The FDA is also investigating whether patients' genetic background can interfere with effectiveness.
MORE ON THIS TOPIC